Nichola I. Johnson

London, ENG SW73RP, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Journal: Cancers

Published: September 09, 2025

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Journal: medRxiv : the preprint server for health sciences

Published: March 17, 2025

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Journal: Breast cancer research : BCR

Published: August 12, 2024

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2024

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Journal: Research square

Published: February 24, 2023

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Journal: Cancer medicine

Published: February 21, 2023

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Journal: Journal of medical genetics

Published: January 26, 2023

A high-fidelity quantum matter-link between ion-trap microchip modules.

A high-fidelity quantum matter-link between ion-trap microchip modules.

Journal: Nature communications

Published: June 30, 2022

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Journal: Cancers

Published: April 09, 2021

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

Journal: American journal of human genetics

Published: October 20, 2020

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Journal: British journal of cancer

Published: April 27, 2020

Showing 1-12 of 67

Last Updated: 09/26/2026